Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Cancers|January 12, 2021
Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of VersicanDavid Brunn, Kati Turkowski, Stefan Günther, et al.American Journal of Respiratory and Critical Care Medicine|December 14, 2011
Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertensionSoni S Pullamsetti, Carmen Doebele, Ariane Fischer, et al.Cancer Research|August 21, 2020
Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and InflammationNefertiti El-Nikhely, Annika Karger, Poonam Sarode, et al.Plos One|November 28, 2018
Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosisMartina Korfei, Daniel Stelmaszek, BreAnne MacKenzie, et al.Oncotarget|September 9, 2017
Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertensionAurélie Hautefort, Julie Chesné, Jens Preussner, et al.Pulmonary Circulation|November 26, 2020
Effects of macitentan and tadalafil monotherapy or their combination on the right ventricle and plasma metabolites in pulmonary hypertensive ratsArgen Mamazhakypov, Astrid Weiß, Sven Zukunft, et al.American Journal of Respiratory and Critical Care Medicine|September 8, 2012
Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertensionRajkumar Savai, Soni S Pullamsetti, Julia Kolbe, et al.Circulation Research|October 15, 2013
MicroRNA-124 controls the proliferative, migratory, and inflammatory phenotype of pulmonary vascular fibroblastsDaren Wang, Hui Zhang, Min Li, et al.International Journal of Cardiology|October 14, 2018
Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018Andrea Olschewski, Eva M Berghausen, Christina A Eichstaedt, et al.Nature Reviews. Cardiology|December 7, 2021
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspectiveSarah Halawa, Soni S Pullamsetti, Charles R M Bangham, et al.Pageof 5